Is cotrimoxazole safe and efficacious for treatment of skin sores in Aboriginal children: a pilot study

Phase 2

Completed

• Conditions: Impetigo; Infection - Other infectious diseases

• Registration Number: ACTRN12607000592448
• Lead Sponsor: Menzies School of Health Research

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2007-11-19
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Diagnosis of purulent or crusted impetigo.

Exclusion Criteria

1. Receipt of any antibiotic in the previous seven days, or receipt of benzathine penicillin in the previous 30 days.
2. The presence of impetigo lesions that are only flat-dry” (i.e. lesions that are not purulent or crusted)
3. Known allergy to penicillin, sulphonamide drugs or trimethoprim, or other constituents of study medications.
4. Immunocompromised.
5. Acute or chronic dermatosis.
6. Evidence of sepsis, cellulitis, bullous impetigo, boils or carbuncles.

Study & Design

• Study Type: Interventional
• Study Design: Not specified